CHRISTOPHER GENE WANG M.D NPI 1083856157

NPI Information

  • NPI: 1083856157
  • Provider Name: CHRISTOPHER GENE WANG, M.D
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2022 BROOKWOOD MEDICAL CTR DR
    AMBULATORY CARE CENTER, STE 628
    BIRMINGHAM, AL
    ZIP 35209
  • Phone: (205) 870-4783

Map and Directions

Get Directions

NPI Details

Christopher Gene Wang, M.D is a hematology and oncology internal medicine in Birmingham, AL with 17 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Christopher Gene Wang, M.D NPI is 1083856157. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

2022 BROOKWOOD MEDICAL CTR DR
AMBULATORY CARE CENTER, STE 628
BIRMINGHAM, AL
ZIP 35209-808
Phone: (205) 870-4783

The NPI 1083856157 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, immune globulin (bivigam), 500 mg (HCPCS:J1556)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)

The enumeration date for this NPI number is 4/3/2009 and was last updated on 12/15/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology31731ALABAMAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.